This page shows the latest autoimmune disease news and features for those working in and with pharma, biotech and healthcare.
added. Aside from PT101, Pandion’s pipeline also includes PD-1 agonists in development for a range of autoimmune diseases. ... Pandion grew out of our founders’ personal and scientific mission to change the way patients living with autoimmune
In January 2020, Horizon received FDA approval for its thyroid eye disease (TED) treatment Tepazza. ... Tepezza is the first medicine approved for the rare autoimmune disease, which can cause eye bulging, facial disfigurement and vision loss.
The deal will see J&J’s Janssen unit gain full access to Momenta’s portfolio of investigational autoimmune disease drugs, including anti-FcRn antibody nipocalimab, which is currently being developed ... J&J already has high stakes in the autoimmune
In addition to ‘168, Sanofi gains rights to rilzabrutinib, an oral BTK inhibitor in development for the treatment of the rare autoimmune disease severe pemphigus and PRN473 Topical, a topical agent ... This acquisition strengthened the company’s
So far, IL-12 as a target in immunotherapy has not gone beyond the hypothetical, as overproduction of IL-12 cytokines is also indicated in a number of inflammatory and autoimmune ... disease, including psoriasis and arthritis.
At the time the biotech said it would focus on potential therapies for cancer and autoimmune conditions, with its operations supported by GSK’s drug discovery capabilities. ... Last year, Lilly announced a $650m partnership with US biotech ImmuNext in
More from news
Approximately 6 fully matching, plus 74 partially matching documents found.
ecosystem. In her 25-plus years in the sector, her investments have resulted in the launch of six drugs, spanning inflammatory and autoimmune disease and cancer.
Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to
Transformative medicine use. The overwhelming inertia in medicine use - where 97% of medicines used have been available for more than ten years - masks the contribution from transformative disease treatments, orphan drugs ... Disease treatments in 2020
Lumena develops oral products for treating liver disease and has two oral inhibitors of the apical sodium-dependent bile acid transporter (ASBT) in phase II to improve liver function. ... MGD010 a B-cell targeted monoclonal antibody for treatment of
The report found that the economic impact of a rare disease can be truly devastating. ... A UK patient with mixed connective tissue disease (an autoimmune rare disease which has the signs and symptoms of lupus, scleroderma, polymyositis, and rheumatoid
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease
His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and ... As Akari continues its mission to develop
biopharma as it focuses on the development and commercialisation of orphan autoimmune and inflammatory disease treatments.
Dr Payton joins the metabolic disease specialist - a spin-out company from the Universities of Glasgow and Southern Denmark - from MAPBiotech, where he has served as chief executive officer since 2014. ... He co-founded autoimmune disease-focused Orca
In his new position at autoimmune disease specialists SuppreMol, Schollmeier succeeds Professor Peter Buckell who retires. ... He said: "The company has a very promising product candidate for the treatment of autoimmune diseases in phase II clinical
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
The other side of … Crohn’s disease. “After visiting about seven doctors in two different countries, I am confident to say that all can align on 2–3 points at most”. ... Meet Irene. Like millions of others worldwide (and an estimated 115, 000
parent of a son recently diagnosed with PANDAS (paediatric autoimmune neuropsychiatric disorder associated with Streptococcus)…. ... As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to progressive and permanent disability. ... In RRMS symptoms are intermittent but relapses gradually become more frequent, severe and
Herceptin, Avastin, Rituximab and Erbitux) and autoimmune disease (e.g. Humira, Enbrel, Remicade, MabThera and RoActemra to name a few).
More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...